Cellebrite DI Ltd.
CLBT
$15.81
-$0.19-1.19%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | 362.49M | 343.46M | 325.11M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 362.49M | 343.46M | 325.11M | |
| Cost of Revenue | -- | 57.32M | 54.09M | 53.23M | |
| Gross Profit | -- | 305.17M | 289.37M | 271.88M | |
| SG&A Expenses | -- | 165.87M | 160.57M | 154.26M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 312.28M | 301.11M | 291.87M | |
| Operating Income | -- | 50.21M | 42.35M | 33.24M | |
| Income Before Tax | -- | -96.84M | -106.25M | -75.56M | |
| Income Tax Expenses | -- | 6.49M | 5.61M | 5.54M | |
| Earnings from Continuing Operations | -- | -103.33 | -111.87 | -81.10 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -103.33M | -111.87M | -81.10M | |
| EBIT | -- | 50.21M | 42.35M | 33.24M | |
| EBITDA | -- | 60.46M | 52.59M | 43.25M | |
| EPS Basic | -- | -0.52 | -0.58 | -0.43 | |
| Normalized Basic EPS | -- | -0.11 | -0.14 | -0.14 | |
| EPS Diluted | -- | -0.53 | -0.59 | -0.45 | |
| Normalized Diluted EPS | -- | -0.11 | -0.14 | -0.14 | |
| Average Basic Shares Outstanding | -- | 781.78M | 770.96M | 760.48M | |
| Average Diluted Shares Outstanding | -- | 794.61M | 783.79M | 773.30M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |